V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212150 | 20174605 | 1.74 | 114 | null | 2019-01-03 | 2019-01-06 | Docetaxel | 02 | null | DOCETAXEL | 100599325 |
| 20212162 | 20174606 | 1.81 | 84 | Palliative (P) | 2021-03-03 | 2021-03-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 100304192 |
| 20212166 | 20174608 | 1.83 | 56.2 | Palliative (P) | 2018-07-25 | 2018-08-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100807243 |
| 20212170 | 20174609 | 1.81 | 104 | Adjuvant (A) | 2022-01-31 | 2022-02-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100411649 |
| 20212186 | 20174610 | 1.52 | 101.3 | null | 2018-05-12 | 2018-05-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101269498 |
| 20212190 | 20174611 | 1.76 | 73.8 | null | 2019-11-23 | 2020-07-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100065718 |
| 20212218 | 20174613 | 1.62 | 79.4 | Palliative (P) | 2016-10-24 | 2016-11-08 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100013972 |
| 20212237 | 20174614 | 1.67 | 69.2 | null | 2021-07-19 | 2021-07-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101733458 |
| 20212238 | 20174615 | 1.61 | 75.8 | Palliative (P) | 2017-09-19 | 2017-09-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100358011 |
| 20212246 | 20174616 | 1.7 | 80 | Palliative (P) | 2018-09-13 | 2020-04-10 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101227608 |
| 20212248 | 20174617 | 1.7 | 64 | null | 2021-02-18 | 2021-02-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101302826 |
| 20212257 | 20174618 | 1.5 | 44.8 | Palliative (P) | 2019-01-22 | 2020-02-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100092045 |
| 20212262 | 20174619 | 1.67 | 65 | Palliative (P) | 2018-02-18 | 2018-03-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100124589 |
| 20212268 | 20174620 | 1.51 | 94.1 | Palliative (P) | 2021-02-19 | 2021-03-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100335970 |
| 20212270 | 20174621 | 1.54 | 54.2 | null | 2016-06-28 | 2016-07-15 | Docetaxel | 02 | null | DOCETAXEL | 101495003 |
| 20212273 | 20174622 | 1.76 | 60.2 | Palliative (P) | 2020-06-25 | 2020-07-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100213554 |
| 20212281 | 20174623 | 1.61 | null | Adjuvant (A) | 2022-02-12 | 2022-03-01 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100292518 |
| 20212289 | 20174624 | 1.71 | 74.8 | Palliative (P) | 2016-08-13 | 2016-10-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100277136 |
| 20212291 | 20174625 | 1.66 | 59.3 | Palliative (P) | 2021-08-14 | 2021-08-18 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101774599 |
| 20212302 | 20174626 | 1.74 | 87.9 | Palliative (P) | 2019-11-29 | 2019-12-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100519828 |
| 20212305 | 20174627 | 1.74 | 65.3 | Palliative (P) | 2015-11-06 | 2018-04-20 | Docetaxel | 02 | N | DOCETAXEL | 101272450 |
| 20212308 | 20174628 | 1.68 | 89.45 | Palliative (P) | 2018-07-22 | 2018-08-08 | Docetaxel | 02 | N | DOCETAXEL | 101438679 |
| 20212310 | 20174629 | 1.62 | 72.2 | Palliative (P) | 2022-03-05 | 2022-03-19 | Docetaxel | 02 | N | DOCETAXEL | 101273272 |
| 20212311 | 20174630 | null | 104.3 | Palliative (P) | 2021-12-24 | 2021-12-29 | CETUXIMAB + IRINOTECAN + MDG | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101666104 |
| 20212321 | 20174631 | 1.74 | 84 | Palliative (P) | 2019-12-30 | 2020-01-03 | Docetaxel | 02 | N | DOCETAXEL | 100321559 |
| 20212335 | 20174632 | 1.7 | 83.9 | Palliative (P) | 2020-03-14 | 2020-04-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100702631 |
| 20212341 | 20174633 | 1.74 | 59.3 | Palliative (P) | 2020-09-05 | 2020-09-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101051931 |
| 20212347 | 20174635 | 1.83 | 69.5 | Palliative (P) | 2017-09-26 | 2018-01-05 | Docetaxel | 02 | N | DOCETAXEL | 100714254 |
| 20212371 | 20174637 | 2 | 70 | Palliative (P) | 2022-02-06 | 2022-02-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 100310925 |
| 20212381 | 20174638 | 1.66 | 79.5 | null | 2021-07-29 | 2021-07-31 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101719806 |
| 20212385 | 20174639 | 1.67 | 93.45 | Palliative (P) | 2016-11-06 | 2016-11-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100623997 |
| 20212386 | 20174640 | 1.7 | 84 | Palliative (P) | 2018-12-29 | 2019-03-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101207401 |
| 20212393 | 20174641 | 1.76 | 71.8 | Palliative (P) | 2022-01-15 | 2022-01-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100060888 |
| 20212394 | 20174642 | 1.59 | 56.6 | Palliative (P) | 2017-10-21 | 2017-10-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101367110 |
| 20212401 | 20174643 | 1.81 | 63 | Palliative (P) | null | 2017-01-19 | Gemcitabine + Capecitabine | 99 | N | CAPECITABINE + GEMCITABINE | 100495119 |
| 20212402 | 20174644 | 1.7 | 46 | null | 2020-08-21 | 2020-08-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 101772809 |
| 20212416 | 20174645 | 1.67 | 99.6 | Curative (C) | 2019-04-11 | 2019-07-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101804402 |
| 20212427 | 20174646 | 1.85 | 88 | Palliative (P) | 2021-08-26 | 2021-08-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101165088 |
| 20212428 | 20174647 | 1.61 | 76 | Palliative (P) | 2021-08-25 | 2021-10-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101443647 |
| 20212435 | 20174648 | 1.63 | 84 | Palliative (P) | 2018-08-28 | 2018-09-11 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | DOCETAXEL | 101684398 |
| 20212440 | 20174649 | 1.81 | 76.6 | Palliative (P) | 2021-10-29 | 2021-11-22 | Docetaxel | 02 | N | DOCETAXEL | 100605056 |
| 20212444 | 20174650 | 1.66 | 56.1 | null | 2018-03-28 | 2018-04-29 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100919051 |
| 20212447 | 20174651 | 1.66 | 65.4 | null | 2021-03-20 | 2021-03-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100124259 |
| 20212457 | 20174652 | 1.51 | 35.1 | Palliative (P) | null | 2017-02-04 | TRASTUZUMAB | null | N | TRASTUZUMAB | 101095116 |
| 20212467 | 20174653 | 1.85 | 75 | Curative (C) | null | 2019-10-20 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN | 101797961 |
| 20212478 | 20174654 | null | 70 | Palliative (P) | 2017-10-15 | 2017-10-19 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100498306 |
| 20212482 | 20174655 | 1.78 | 66.3 | null | 2022-02-12 | 2022-03-04 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101059947 |
| 20212488 | 20174656 | 1.76 | 66.4 | Curative (C) | null | 2020-07-15 | Trastuzumab | 02 | N | TRASTUZUMAB | 100362655 |
| 20212496 | 20174657 | 1.61 | 51 | Curative (C) | 2019-10-31 | 2019-11-21 | Trastuzumab | 02 | N | TRASTUZUMAB | 100875894 |
| 20212516 | 20174658 | 1.8 | 56.7 | Curative (C) | 2020-04-18 | 2020-05-14 | CETUXIMAB | N | Y | CETUXIMAB | 100294510 |